Nexalin Technology Company Leadership
| NXL Stock | USD 2.92 0.04 1.39% |
Nexalin Technology's insiders are aggressively buying. The analysis of insiders' sentiment of trading Nexalin Technology stock suggests that most insiders are extremely bullish at this time. Nexalin Technology employs about 6 people. The company is managed by 7 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 0.86 employees per reported executive.
Nexalin Technology's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
| 2025-01-28 | David Owens | Acquired 1500 @ 2.7 | View | ||
| 2025-01-23 | David Owens | Acquired 1000 @ 2.7 | View | ||
| 2025-01-13 | David Owens | Acquired 2000 @ 2.5 | View | ||
| 2024-10-28 | David Owens | Acquired 500 @ 2.19 | View | ||
| 2024-06-28 | David Owens | Acquired 1000 @ 1.75 | View | ||
| 2024-06-10 | David Owens | Acquired 3000 @ 0.64 | View |
Monitoring Nexalin Technology's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Nexalin |
Nexalin Technology Management Team Effectiveness
The company has Return on Asset of (1.1892) % which means that on every $100 spent on assets, it lost $1.1892. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (2.0223) %, meaning that it generated no profit with money invested by stockholders. Nexalin Technology's management efficiency ratios could be used to measure how well Nexalin Technology manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -1.25. Return On Capital Employed is expected to rise to -1.94 this year. At this time, Nexalin Technology's Net Tangible Assets are quite stable compared to the past year. Non Current Assets Total is expected to rise to about 243.9 K this year, although the value of Total Current Assets will most likely fall to about 2.6 M.The value of Common Stock Shares Outstanding is expected to slide to about 8 M. The value of Net Loss is expected to slide to about (2.1 M)
Nexalin Technology Workforce Comparison
Nexalin Technology is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 4,357. Nexalin Technology adds roughly 6.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Nexalin Technology Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nexalin Technology insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nexalin Technology's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Nexalin Technology insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2022-09-01 | 8.0 | 16 | 2 | 286,000 | 0.00 |
| 2007-03-01 | 11.0 | 11 | 1 | 78,440 | 3,000 |
| 2006-12-01 | 2.0 | 4 | 2 | 6,221 | 9,328 |
| 2006-09-01 | 0.5455 | 6 | 11 | 21,666 | 59,146 |
| 2006-06-01 | 1.0 | 11 | 11 | 73,636 | 118,600 |
| 2006-03-01 | 3.0 | 9 | 3 | 123,342 | 38,380 |
| 2005-12-01 | 1.6667 | 5 | 3 | 6,115 | 10,000 |
| 2005-09-01 | 32.0 | 32 | 1 | 74,101 | 4,900 |
| 2005-03-01 | 2.5 | 5 | 2 | 48,310 | 24,000 |
| 2004-12-01 | 0.6 | 15 | 25 | 55,408 | 110,000 |
| 2004-09-01 | 2.0 | 4 | 2 | 2,447 | 3,715 |
| 2004-06-01 | 2.3333 | 7 | 3 | 13,986 | 4,237 |
| 2004-03-01 | 5.0 | 5 | 1 | 48,719 | 19,280 |
| 2003-12-01 | 0.7143 | 5 | 7 | 112,953 | 225,000 |
| 2003-09-01 | 0.5455 | 6 | 11 | 39,821 | 78,931 |
| 2003-06-01 | 3.0 | 3 | 1 | 10,750 | 37,120 |
Nexalin Technology Notable Stakeholders
A Nexalin Technology stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nexalin Technology often face trade-offs trying to please all of them. Nexalin Technology's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nexalin Technology's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| John Claude | CoFounder Development | Profile | |
| Mark White | CEO, President | Profile | |
| Marilyn Elson | Chief Officer | Profile | |
| Joel Bradus | Director Marketing | Profile | |
| Carolyn Shelton | Regulatory Quality | Profile | |
| David MD | Chief Director | Profile | |
| Michael Nketiah | Regulatory Quality | Profile |
About Nexalin Technology Management Performance
The success or failure of an entity such as Nexalin Technology often depends on how effective the management is. Nexalin Technology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nexalin management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nexalin management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.19) | (1.25) | |
| Return On Capital Employed | (2.04) | (1.94) | |
| Return On Assets | (1.15) | (1.21) | |
| Return On Equity | (1.67) | (1.58) |
Nexalin Technology Workforce Analysis
Traditionally, organizations such as Nexalin Technology use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nexalin Technology within its industry.Nexalin Technology Manpower Efficiency
Return on Nexalin Technology Manpower
| Revenue Per Employee | 18.5K | |
| Revenue Per Executive | 15.8K | |
| Net Loss Per Employee | 774.8K | |
| Net Loss Per Executive | 664.1K | |
| Working Capital Per Employee | 500.8K | |
| Working Capital Per Executive | 429.2K |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.65) | Revenue Per Share | Quarterly Revenue Growth (0.24) | Return On Assets | Return On Equity |
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.